SonarPore

Japan · Biotech

SonarPore develops single-molecule measurement technology for blood-based cancer testing.

Product

SonarPore measures individual molecules as they pass through nanoscale pores, converting their characteristics into electrical signals. Machine learning then analyses patterns across the measured population.

The University of Tokyo spinout is researching how this approach could distinguish cancer-related changes from inflammation. It aims to provide additional information when conventional tumour markers or imaging leave questions unresolved.

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
1stRound non-equity supportUndisclosedUTokyo Innovation Platform Co — Participant
Sourcessonarpore.jp ↗utokyo-ipc.co.jp ↗